These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 18772127)
1. Regulation of receptor signaling by relaxin A chain motifs: derivation of pan-specific and LGR7-specific human relaxin analogs. Park JI; Semyonov J; Yi W; Chang CL; Hsu SY J Biol Chem; 2008 Nov; 283(46):32099-109. PubMed ID: 18772127 [TBL] [Abstract][Full Text] [Related]
2. Defining the LGR8 residues involved in binding insulin-like peptide 3. Scott DJ; Wilkinson TN; Zhang S; Ferraro T; Wade JD; Tregear GW; Bathgate RA Mol Endocrinol; 2007 Jul; 21(7):1699-712. PubMed ID: 17473281 [TBL] [Abstract][Full Text] [Related]
3. Genetic targeting of relaxin and insl3 signaling in mice. Feng S; Bogatcheva NV; Kamat AA; Agoulnik AI Ann N Y Acad Sci; 2005 May; 1041():82-90. PubMed ID: 15956690 [TBL] [Abstract][Full Text] [Related]
4. Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo. Bathgate RA; Lin F; Hanson NF; Otvos L; Guidolin A; Giannakis C; Bastiras S; Layfield SL; Ferraro T; Ma S; Zhao C; Gundlach AL; Samuel CS; Tregear GW; Wade JD Biochemistry; 2006 Jan; 45(3):1043-53. PubMed ID: 16411781 [TBL] [Abstract][Full Text] [Related]
5. The A-chain of human relaxin family peptides has distinct roles in the binding and activation of the different relaxin family peptide receptors. Hossain MA; Rosengren KJ; Haugaard-Jönsson LM; Zhang S; Layfield S; Ferraro T; Daly NL; Tregear GW; Wade JD; Bathgate RA J Biol Chem; 2008 Jun; 283(25):17287-97. PubMed ID: 18434306 [TBL] [Abstract][Full Text] [Related]
6. H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. Sudo S; Kumagai J; Nishi S; Layfield S; Ferraro T; Bathgate RA; Hsueh AJ J Biol Chem; 2003 Mar; 278(10):7855-62. PubMed ID: 12506116 [TBL] [Abstract][Full Text] [Related]
7. The NMR solution structure of the relaxin (RXFP1) receptor lipoprotein receptor class A module and identification of key residues in the N-terminal region of the module that mediate receptor activation. Hopkins EJ; Layfield S; Ferraro T; Bathgate RA; Gooley PR J Biol Chem; 2007 Feb; 282(6):4172-84. PubMed ID: 17148455 [TBL] [Abstract][Full Text] [Related]
8. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8). Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866 [TBL] [Abstract][Full Text] [Related]
9. Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity. Muda M; He C; Martini PG; Ferraro T; Layfield S; Taylor D; Chevrier C; Schweickhardt R; Kelton C; Ryan PL; Bathgate RA Mol Hum Reprod; 2005 Aug; 11(8):591-600. PubMed ID: 16051677 [TBL] [Abstract][Full Text] [Related]
10. Solution structure and novel insights into the determinants of the receptor specificity of human relaxin-3. Rosengren KJ; Lin F; Bathgate RA; Tregear GW; Daly NL; Wade JD; Craik DJ J Biol Chem; 2006 Mar; 281(9):5845-51. PubMed ID: 16365033 [TBL] [Abstract][Full Text] [Related]
11. Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique low density lipoprotein class A modules. Scott DJ; Layfield S; Yan Y; Sudo S; Hsueh AJ; Tregear GW; Bathgate RA J Biol Chem; 2006 Nov; 281(46):34942-54. PubMed ID: 16963451 [TBL] [Abstract][Full Text] [Related]
12. The low-density lipoprotein class A module of the relaxin receptor (leucine-rich repeat containing G-protein coupled receptor 7): its role in signaling and trafficking to the cell membrane. Kern A; Agoulnik AI; Bryant-Greenwood GD Endocrinology; 2007 Mar; 148(3):1181-94. PubMed ID: 17158203 [TBL] [Abstract][Full Text] [Related]
13. The complex binding mode of the peptide hormone H2 relaxin to its receptor RXFP1. Sethi A; Bruell S; Patil N; Hossain MA; Scott DJ; Petrie EJ; Bathgate RAD; Gooley PR Nat Commun; 2016 Apr; 7():11344. PubMed ID: 27088579 [TBL] [Abstract][Full Text] [Related]
14. Relaxin enhances the oncogenic potential of human thyroid carcinoma cells. Hombach-Klonisch S; Bialek J; Trojanowicz B; Weber E; Holzhausen HJ; Silvertown JD; Summerlee AJ; Dralle H; Hoang-Vu C; Klonisch T Am J Pathol; 2006 Aug; 169(2):617-32. PubMed ID: 16877360 [TBL] [Abstract][Full Text] [Related]
15. Relaxin research in the postgenomic era. Kawamura K; Sudo S; Kumagai J; Pisarska M; Hsu SY; Bathgate R; Wade J; Hsueh AJ Ann N Y Acad Sci; 2005 May; 1041():1-7. PubMed ID: 15956679 [TBL] [Abstract][Full Text] [Related]
16. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7. Liu C; Chen J; Kuei C; Sutton S; Nepomuceno D; Bonaventure P; Lovenberg TW Mol Pharmacol; 2005 Jan; 67(1):231-40. PubMed ID: 15465925 [TBL] [Abstract][Full Text] [Related]
17. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation. Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387 [TBL] [Abstract][Full Text] [Related]
18. Studies on soluble ectodomain proteins of relaxin (LGR7) and insulin 3 (LGR8) receptors. Yan Y; Cai J; Fu P; Layfield S; Ferraro T; Kumagai J; Sudo S; Tang JG; Giannakis E; Tregear GW; Wade JD; Bathgate RA Ann N Y Acad Sci; 2005 May; 1041():35-9. PubMed ID: 15956685 [TBL] [Abstract][Full Text] [Related]
19. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7. Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155 [TBL] [Abstract][Full Text] [Related]
20. Identification of binding sites with differing affinity and potency for relaxin analogues on LGR7 and LGR8 receptors. Halls ML; Bathgate RA; Sudo S; Kumagai J; Bond CP; Summers RJ Ann N Y Acad Sci; 2005 May; 1041():17-21. PubMed ID: 15956682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]